Home › Glioma › Florida › Miami

Glioma clinical trials in Miami, FL

15 studies for Glioma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

RecruitingPhase 2

Miami Cancer Institute, Miami

Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07326566

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

RecruitingPhase 2

University of Miami Health, Miami

Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07703436

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RecruitingPhase 2

Nicklaus Children's Hospital, Miami

12 Months – 39 Years · All sexes · Updated Oct 23, 2026 · NCT06838676

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3

University of Miami Health, Miami

Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study

University of Miami, Miami

12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2

University of Miami Hospital and Clinics, Miami

Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2

Nicklaus Children's Hospital, Miami

Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2

University of Miami Hospital and Clinics, Miami

Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

RecruitingPhase 2

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05188508

STARLITE for Unresectable High-Grade Gliomas

RecruitingPhase 1

University of Miami, Miami

Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Recruiting

Miami Cancer Institute at Baptist Health, Inc., Miami

Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

RecruitingPhase 2

University of Miami Hospital, Miami

Ages 18 to 75 · All sexes · Updated May 28, 2026 · NCT06264388

Non-invasive Glioma Characterization Through Molecular Imaging

Recruiting

University of Miami, Miami

Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT03684109

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

RecruitingPhase 1/2

University of Miami, Miami

Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

RecruitingPhase 1/2

University of Miami Hospital, Miami

Up to age 18 · All sexes · Updated Nov 20, 2025 · NCT04299191

Glioma trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.